Rakovina Therapeutics Inc. ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to ...

Unlock effective strategies for back pain treatment, including advanced techniques to support healing and reduce discomfort.

The Nitte University Centre for Science Education & Research (NUCSER), a constituent college of Nitte University is part of a ...

Alberto gained a BSc Biotechnology in Valencia in 2019 ... Wayne took an MSc at UCLan. His industrial placement at Zeneca investigated the control of gene expression in embryonic stem cells. Projects ...

So far, we have received 400 applications each for the courses," he said, adding that the demand for BSc (Biotechnology ... besides the infrastructure and placement records, the NIRF and ARIIA ...

The initial exercise date and term of the warrants purchased in the private placement have been corrected to one year ... All other aspects of the announcement remain the same. MAIA Biotechnology, Inc ...

The initial exercise date and term of the warrants purchased in the private placement have been corrected ... CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA ...

(the "Company”, "Kane” or "Kane Biotech”) announces that today it has completed its previously announced non-brokered private placement offering (the "Offering”) of common shares of the Company ...

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $60.65 million, has announced a private placement deal ...

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the ...